Current drug treatment methods and potential significance of glucocorticoid for inoperable advanced thymoma
Authors:
- 30 April 2026
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 284, 109039
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation of Beijing Municipality (L246069)
This publication has 88 references indexed in Scilit:
- Risk factor analysis of thymoma resection and its value in guiding clinical treatmentCancer Medicine, 2023
- Myocarditis and myasthenia gravis induced by immune checkpoint inhibitor in a patient with relapsed thymoma: A case reportClinical Case Reports, 2023
- Macrophage plasticity, polarization, and function in health and diseaseJournal of Cellular Physiology, 2018
- Key components of chemotherapy for thymic malignancies: a systematic review and pooled analysis for anthracycline-, carboplatin- or cisplatin-based chemotherapyJournal of Cancer Research and Clinical Oncology, 2014
- Glucocorticoids induce G1 cell cycle arrest in human neoplastic thymic epithelial cellsJournal of Cancer Research and Clinical Oncology, 2005
- Combined etoposide, ifosfamide, and cisplatin in the treatment of patients with advanced thymoma and thymic carcinomaCancer, 2001
- Histopathologic changes of thymoma preoperatively treated with corticosteroidsVirchows Archiv, 2001
- Neoadjuvant chemotherapy, surgery, and postoperative radiation therapy for invasive thymomaCancer, 1991
- Chemotherapy for invasive thymoma. A 13-year experienceCancer, 1991
- Influence of glucocorticoids on histamine release and45Calcium uptake by isolated rat mast cellsInflammation Research, 1984